EXTON, Pa., May 15, 2017 /PRNewswire/ -- West Pharmaceutical
Services, Inc. (NYSE: WST) today announced that the Company's Board
of Directors has approved a third-quarter 2017 dividend of
$0.13 per share. The dividend will be
paid on August 2, 2017 to
shareholders of record as of July 19,
2017.
The Company also announced that management will be presenting an
overview of the business at three investor conferences in May and
June. Management will present at the Bank of America Merrill Lynch
2017 Health Care Conference, Las Vegas,
Nevada, at 10:00 a.m. PDT on
Wednesday, May 17; the 2017 UBS
Global Healthcare Conference, New York,
New York, at 2:00 p.m. EDT on
Tuesday, May 23; and the Jefferies
2017 Global Healthcare Conference in New
York, New York at 8:30 a.m.
EDT on Tuesday, June 6.
A live audio webcast of each presentation, as well as the
presentation materials, will be accessible from the Company's
website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of
packaging components and delivery systems for injectable drugs and
healthcare products. Working by the side of its customers from
concept to patient, West creates products that promote the
efficiency, reliability and safety of the world's pharmaceutical
drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2016 sales
of $1.5 billion reflect the daily use
of approximately 112 million of its components and devices, which
are designed to improve the delivery of healthcare to patients
around the world.
West and the diamond logo and By your side for a healthier
world™ are registered trademarks or trademarks of West
Pharmaceutical Services, Inc., in the
United States and other jurisdictions.
Investor
Contact:
|
Media
Contact:
|
Quintin
Lai
|
Emily
Denney
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
+1-610-594-3318
|
+1-610-594-3035
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/west-announces-quarterly-dividend-and-participation-in-upcoming-investor-conferences-300457812.html
SOURCE West Pharmaceutical Services, Inc.